The Diabetic Foot Exam: 5 Essential Steps for Independent Practices

A diabetic foot exam is a structured screening that checks the feet of patients with diabetes for the earliest signs of nerve damage and reduced circulation — the two changes that lead to ulcers and amputations. The American Diabetes Association recommends a comprehensive diabetic foot exam at least once a year for every patient with diabetes, and more often for higher-risk feet.

This guide breaks the diabetic foot exam into five essential steps an independent practice can complete in a single visit, and shows where objective vascular and autonomic testing closes the gap that a standard monofilament check leaves open.

What Is a Diabetic Foot Exam and Why Does It Matter?

A diabetic foot exam is a focused physical and neurological assessment that screens for peripheral neuropathy, peripheral artery disease (PAD), skin breakdown, and structural deformity in patients with diabetes. The goal is simple: find the feet at risk before they ulcerate.

The stakes are high. Diabetes is the leading cause of non-traumatic lower-limb amputation, and the large majority of those amputations are preceded by a foot ulcer that began as an unnoticed injury on an insensate foot.

Identifying loss of sensation and poor circulation early lets clinicians intervene with footwear, education, glycemic management, and closer follow-up — steps that may help reduce the risk of ulceration and amputation. According to the American Diabetes Association Standards of Care, every patient with diabetes should receive a comprehensive foot evaluation at least annually, while patients with sensory loss, prior ulceration, or amputation should have their feet inspected at every visit.

What Are the 5 Essential Steps of a Complete Diabetic Foot Exam?

A complete diabetic foot exam combines a careful hands-on assessment with objective measurement. These five steps cover everything the ADA Standards of Care expect a thorough screening to include.

1. Visual skin and structural inspection. Examine the skin for breakdown, calluses, fissures, and color changes; check between the toes and around the nails; and note structural deformities such as bunions, hammertoes, and prominent metatarsal heads that raise plantar pressure and ulcer risk.
2. Loss of protective sensation (LOPS) testing. Use the 10-gram Semmes-Weinstein monofilament at the standard plantar sites, paired with at least one additional test — vibration with a 128-Hz tuning fork or a vibration perception threshold device, pinprick, temperature, or ankle reflexes. The Ipswich touch test is a validated alternative when a monofilament is unavailable.
3. Autonomic and small-fiber screening. This is the early-warning layer most routine exams skip. Sudomotor testing and heart-rate-variability analysis detect autonomic and small-fiber dysfunction that frequently develops before protective sensation is lost.
4. Risk stratification and documentation. Assign an ADA foot-risk category, set the appropriate follow-up interval, and document every finding with the clinical plan. Clear documentation supports continuity of care and clean claims.

How Often Should Patients Have a Diabetic Foot Exam?

Every patient with diabetes should have a comprehensive diabetic foot exam at least once a year. Frequency increases with risk: patients with loss of protective sensation, diagnosed PAD, foot deformity, or a history of ulceration or amputation warrant more frequent evaluation, and the ADA advises inspecting the feet of the highest-risk patients at every clinical visit.

Building a recall workflow around these intervals — and flagging high-risk patients in the EHR — helps a practice stay consistent and audit-ready.

What Are the Diabetic Foot Risk Categories?

After the exam, each patient is placed in a risk category that sets how often the feet should be rechecked. The widely used International Working Group on the Diabetic Foot (IWGDF) system — reflected in the ADA Standards of Care — stratifies risk from very low to high based on loss of protective sensation (LOPS), peripheral artery disease (PAD), foot deformity, and any history of ulceration or amputation. The higher the category, the shorter the recommended screening interval.

Accurate stratification depends on reliably detecting LOPS and PAD — the two findings that move a patient up the scale. This is where objective measurement helps: adding ankle-brachial index and autonomic data to the diabetic foot exam reduces the chance that a patient is under-classified because subtle, early disease was missed on the hands-on exam alone.

Why Does a Standard Diabetic Foot Exam Miss Early Nerve Damage?

The monofilament test is the workhorse of the diabetic foot exam, but it measures loss of protective sensation — a late, large-fiber finding. By the time the monofilament reading is abnormal, meaningful nerve damage has usually already occurred and the foot is at elevated risk.

Small unmyelinated nerve fibers degenerate first. Sudomotor (sweat-gland) dysfunction is recognized as one of the earliest manifestations of diabetic autonomic and small-fiber neuropathy, often appearing in prediabetes and before protective sensation is lost.

Research summarized in Frontiers in Neurology reports that sudomotor testing is among the most sensitive ways to assess small-fiber nerve function. Catching dysfunction at this stage matters because early small-fiber changes may be partly reversible with glycemic control and lifestyle intervention. Adding objective autonomic and vascular measurement to the diabetic foot exam therefore identifies at-risk patients sooner than sensation testing alone.

How the CMAT Advantage Supports the Diabetic Foot Exam

The CMAT Advantage™ from HealthWright Technologies is a diagnostic platform built on FDA-cleared component devices that adds the objective, measurable layers of the diabetic foot exam in a single 7-to-10-minute test. It captures the ankle-brachial index for vascular assessment alongside heart-rate-variability and sudomotor measurements for autonomic and small-fiber function — the early-warning data that a monofilament alone cannot provide. The system generates standardized, color-coded reports for the chart and complements, rather than replaces, the clinician’s hands-on inspection and judgment.

Because the vascular and autonomic components map to long-established procedure codes, a structured screening encounter can support multiple billable CPT codes — for example, ABI testing plus autonomic function testing. Coverage and correct coding vary by payer and remain the responsibility of the practice and its billing team.

For independent practices that already screen for diabetic neuropathy, layering objective autonomic and vascular data onto the annual diabetic foot exam strengthens both clinical insight and the practice’s preventive-care program. To see how it fits an existing workflow, explore the HealthWright partnership program.

Who Should Be Prioritized for Vascular and Autonomic Screening?

Not every encounter needs the full objective workup, but several groups benefit most from adding ABI and autonomic testing to the diabetic foot exam. Professional guidelines from the American College of Cardiology and American Heart Association recommend ankle-brachial index screening for the following adults:

• adults aged 65 and older
• adults 50 and older who have atherosclerosis risk factors or a family history of PAD
• adults younger than 50 who have diabetes plus at least one additional risk factor such as smoking, hypertension, or high cholesterol

Within a diabetes population, the highest-yield candidates for early autonomic and vascular screening include patients with long-standing diabetes, suboptimal glycemic control, established cardiovascular disease, or symptoms such as burning feet, numbness, exertional leg pain, or slow-healing wounds.

Prioritizing these patients keeps a screening program focused and clinically meaningful, and it helps ensure the patients most likely to have silent disease are identified before complications develop. Capturing objective baselines also makes year-over-year comparison possible, so subtle progression is easier to spot at the next visit.

Diabetic Foot Exam: What Each Component Detects

Frequently Asked Questions About the Diabetic Foot Exam

What is included in a diabetic foot exam?

A complete diabetic foot exam includes a visual skin and structural inspection, testing for loss of protective sensation with a 10-gram monofilament plus at least one additional sensory test, a vascular assessment of the pedal pulses (and an ankle-brachial index when indicated), and ideally objective autonomic and small-fiber screening, followed by risk stratification and documentation.

How often should a diabetic foot exam be done?

The American Diabetes Association recommends a comprehensive diabetic foot exam at least once a year for every patient with diabetes. Patients with loss of protective sensation, peripheral artery disease, foot deformity, or a prior ulcer or amputation should be examined more frequently — often at every visit.

Can a diabetic foot exam detect nerve damage early?

A standard monofilament test detects nerve damage only after protective sensation is already lost. Adding objective autonomic and small-fiber screening, such as sudomotor and heart-rate-variability testing, can identify dysfunction earlier, because small-fiber and autonomic changes often precede measurable loss of protective sensation.

What ABI value indicates peripheral artery disease?

An ankle-brachial index of 0.90 or lower is generally considered diagnostic of peripheral artery disease. Values between 0.91 and 1.40 are typically normal, while values above 1.40 suggest non-compressible, calcified arteries and may require additional testing such as a toe-brachial index.

How is diabetic foot ulcer risk classified?

The IWGDF system used in the ADA Standards of Care sorts patients into four categories: very low (no loss of protective sensation and no PAD, screened yearly), low (LOPS or PAD, every 6–12 months), moderate (two of LOPS, PAD, or foot deformity, every 3–6 months), and high (LOPS or PAD plus a prior ulcer, amputation, or end-stage renal disease, every 1–3 months). The category determines how often the diabetic foot exam should be repeated.

Conclusion

A thorough diabetic foot exam protects patients from the diabetes complications that are most preventable with early detection. The five-step workflow — inspection, sensation testing, vascular assessment, autonomic and small-fiber screening, and risk stratification — gives independent practices a repeatable standard, and objective vascular and autonomic measurement extends that standard to find at-risk feet sooner.

To learn how the CMAT Advantage can add objective ABI and autonomic testing to your diabetic foot exam workflow, contact HealthWright Technologies at (678) 322-7146 or email contact@healthwrighttechnologies.com.

This article is for educational purposes for healthcare professionals and does not constitute medical or billing advice. Patients should consult their healthcare provider about their individual care. CPT codes are referenced for general information only; CPT® is a registered trademark of the American Medical Association, and code applicability, coverage, and reimbursement should be verified with each payer.

References

• Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes — American Diabetes Association
• Peripheral Artery Disease: Screening With the Ankle-Brachial Index — U.S. Preventive Services Task Force
• Sudomotor Testing of Diabetes Polyneuropathy — Frontiers in Neurology
• IWGDF Practical Guidelines on the Prevention and Management of Diabetes-Related Foot Disease (2023) — International Working Group on the Diabetic Foot

Related Articles

• TM-Flow System and Diabetic Neuropathy: Early Detection Strategies
• Understanding Sudomotor Testing: A Comprehensive Guide
• From PAD Screening to ANS Analysis: 3 CPT Codes From One CMAT Visit